ZA200901216B - Method for treating cancer harboring EGFR mutations - Google Patents

Method for treating cancer harboring EGFR mutations

Info

Publication number
ZA200901216B
ZA200901216B ZA200901216A ZA200901216A ZA200901216B ZA 200901216 B ZA200901216 B ZA 200901216B ZA 200901216 A ZA200901216 A ZA 200901216A ZA 200901216 A ZA200901216 A ZA 200901216A ZA 200901216 B ZA200901216 B ZA 200901216B
Authority
ZA
South Africa
Prior art keywords
treating cancer
egfr mutations
cancer harboring
harboring egfr
mutations
Prior art date
Application number
ZA200901216A
Other languages
English (en)
Inventor
Flavio Solca
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200901216B publication Critical patent/ZA200901216B/xx

Links

ZA200901216A 2006-09-18 2009-02-20 Method for treating cancer harboring EGFR mutations ZA200901216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06120856 2006-09-18

Publications (1)

Publication Number Publication Date
ZA200901216B true ZA200901216B (en) 2010-03-31

Family

ID=41040415

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901216A ZA200901216B (en) 2006-09-18 2009-02-20 Method for treating cancer harboring EGFR mutations

Country Status (2)

Country Link
CN (1) CN101516376A (xx)
ZA (1) ZA200901216B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140139510A (ko) * 2012-03-28 2014-12-05 다나-파버 캔서 인스티튜트 인크. Raf 억제제에 대한 내성을 부여하는 c-raf 돌연변이체
CN103575900B (zh) * 2012-07-23 2015-10-21 苏州长光华医生物试剂有限公司 一种检测erbb2蛋白的试剂盒及其制备方法
CN105420194B (zh) * 2015-12-21 2019-11-19 中南大学湘雅医院 mPRα介导孕酮调节肺腺癌细胞对EGFR-TKIs敏感性的方法
AU2017363199B2 (en) * 2016-11-17 2023-08-17 Board Of Regents, The University Of Texas System Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations
CN111527103A (zh) * 2017-09-08 2020-08-11 科罗拉多大学董事会,法人团体 用于治疗或预防her驱动的抗药性癌症的化合物、组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102886045A (zh) * 2005-02-03 2013-01-23 综合医院公司 治疗吉非替尼耐药性癌症的方法

Also Published As

Publication number Publication date
CN101516376A (zh) 2009-08-26

Similar Documents

Publication Publication Date Title
IL197914A (en) Antibodies to ereg for cancer treatment
IL198851A0 (en) Methods for treating hypercholesterolemia
GB2445867B (en) Method for reducing acrylamide formation
EP1909854A4 (en) METHOD FOR TREATING CANCER
ZA200904983B (en) Method for reducing acrylamide formation
EP1991230A4 (en) METHOD FOR THE TREATMENT OF CANCER
HK1131577A1 (en) Compositions for treating cancer
ZA200805760B (en) Method for treating disseminated cancer
ZA201003123B (en) Thiazol derivavtives for treating cancer
IL213398A0 (en) Compounds for treating cancer
IL196208A0 (en) Methods for cancer treatment using tak1 inhibitors
EP2144504A4 (en) METHOD FOR COMBATING BRAIN CANCER
IL238394A0 (en) Cancer treatment method
IL199689A0 (en) Compounds and method for treatment of cancer
EP2144888A4 (en) METHODS OF TREATING CANCER
ZA200901216B (en) Method for treating cancer harboring EGFR mutations
EP2029172A4 (en) ANTI-C35 ANTIBODIES FOR THE TREATMENT OF CANCER
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2035439A4 (en) RISK ASSESSMENT FOR COLORECTAL CANCER
EP2088862A4 (en) METHOD OF TREATING CANCER
EP2068911A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP2281575A4 (en) ANTIBODIES FOR THE TREATMENT OF CANCER
HK1225304A1 (zh) 治療骨癌
PT2509599E (pt) Processo para o tratamento de cancro pancreático
GB0707556D0 (en) Treatment for cancer